MEREO BIOPHARMA GROUP PLC

Insiders Mereo BioPharma Group plc

Equities

MREO

US5894921072

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-10 EDT			5-day change	1st Jan Change
3.03 ^USD	-7.34%		-7.06%	+31.17%

05-10	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	MT
05-03	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mereo BioPharma Group plc Announces Board Changes	22-10-28	CI
Mereo BioPharma Group plc Announces Board Changes	22-05-17	CI
Mereo BioPharma Group plc Announces Appointment of Anne Hyland to Board of Directors	22-03-01	CI
Mereo Biopharma Announces Board Changes	21-09-20	CI
Mereo Biopharma Group plc Announces the Appointment of Suba Krishnan, M.D. as Senior Vice President of Clinical Development, Effective December 7, 2020	20-11-23	CI
Mereo Biopharma Group plc Appoints Heidi Petersen as Senior Vice President, Regulatory Affairs	20-10-20	CI
Mereo BioPharma Group plc Announces Changes to Board of Directors	20-09-28	CI
Mereo Biopharma Group plc Appoints Michael Wyzga as Interim Chief Financial Officer	20-08-03	CI
Mereo Biopharma Group plc Cease Michael Wyzga as Member of Audit and Risk Committee	20-08-03	CI
Richard Jones Announces Step Down from the Board of Mereo BioPharma Group plc	20-06-30	CI
Mereo BioPharma Group plc Appoints John Lewicki, as Chief Scientific Officer and Ann Kapoun as SVP of Translational Research and Development	20-06-30	CI
Mereo BioPharma Group plc Appoints Arun Mistry as Therapeutic Area Head, Setrusumab	19-09-17	CI
Mereo BioPharma Group plc Appoints Richard Francis as Head of Pharmaceutical Development, Effective August 1, 2019	19-07-16	CI
Mereo BioPharma Group plc Announces Board Appointments	19-04-23	CI
Mereo Biopharma Group plc Announces Board Changes	19-02-11	CI
Mereo BioPharma Group plc Announces Board Appointments	18-12-05	CI
Mereo BioPharma Group plc Appoints Wills Hughes-Wilson as Head of Patient Access and Commercial Planning	18-02-26	CI
Mereo Biopharma Group plc Appoints Richard CM Jones as Chief Financial Officer and Board of Director	16-11-07	CI
Richard Bungay to Leave Mereo BioPharma Group plc as Chief Financial Officer and Chief Operating Officer in April 2017	16-10-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW